Prognostic value of body composition and nutritional assessment in recurrent/metastatic squamous cell carcinoma of head and neck (R/M SCCHN) treated with immunotherapy (IO)

被引：0
|
作者：
Vidales Sepulveda, Z. [1 ]
Choulli, M. [2 ]
Fabrego, S. [2 ]
Pallares, N. [3 ]
Santos, N. [3 ]
Llop Serna, S. [1 ]
Brenes Castro, J. [1 ]
Plana Serrahima, M. [4 ]
Juarez Lozano, C. M. [5 ]
Brunet, A. [6 ]
Melero, M. [7 ]
Bermejo, O. [8 ]
Vilajosana, E. [1 ,9 ]
Godino, C. [10 ]
Oliva, M. [11 ]
Arribas, L. [12 ]
机构：
[1] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[2] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Nutr Dept, Lhospitalet De Llobregat, Spain
[3] IDIBELL Bellvitge Biomed Res Inst, Biostat Unit, Lhospitalet De Llobregat, Spain
[4] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Barcelona, Spain
[5] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Radiat Oncol, Barcelona, Spain
[6] Hosp Univ Bellvitge, Otolaryngol Dept, Lhospitalet De Llobregat, Spain
[7] Hosp Univ Bellvitge, Oral & Maxillofacial Surg Dept, Lhospitalet De Llobregat, Spain
[8] Hosp Univ Bellvitge, Plast Surg Dept, Lhospitalet De Llobregat, Spain
[9] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[10] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Med Oncol Dept, Barcelona, Spain
[11] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Moliva Iconcol Net, Barcelona, Spain
[12] Inst Catala Oncol, Clin Nutr Unit, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2072
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
928P
引用
收藏
页码：S585 / S586
页数：2
相关论文
共 50 条
  • [41] Optimizing brief, focused symptom assessment in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): The FHNSI-10.
    Shaunfield, Sara
    Yount, Susan
    Boyken, Lara
    Stoykova, Boyka
    Agulnik, Mark
    Samant, Sandeep
    Cella, David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe
    Prianka Singh
    Bryan Bennett
    Tom Bailey
    Gavin Taylor-Stokes
    Ivana Rajkovic
    Marta Contente
    Sharon Curtis
    Chris Curtis
    BMC Cancer, 21
  • [43] Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe
    Singh, Prianka
    Bennett, Bryan
    Bailey, Tom
    Taylor-Stokes, Gavin
    Rajkovic, Ivana
    Contente, Marta
    Curtis, Sharon
    Curtis, Chris
    BMC CANCER, 2021, 21 (01)
  • [44] Single Agent Irinotecan for The Treatment of Metastatic or Recurrent Squamous Carcinoma of the Head and Neck (SCCHN)
    Gilbert, J.
    Dang, T.
    Cmelak, A.
    Shyr, Y.
    Netterville, J.
    Burkey, B.
    Chung, C. H.
    Ikpeazu, E.
    Murphy, B. A.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2007, 1 : 59 - 63
  • [45] Locoregional vs. distant relapse: Impact on survival in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immunotherapy
    Alouani, E. L.
    Piram, L.
    Chaltiel, L.
    Rigal, S.
    Delord, J-P.
    Bastien, C.
    Gomez-Roca, C. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S801 - S802
  • [46] Established treatment concepts for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSSC)
    Kloppenburg, Marcel
    Mildner, Finn
    Kasseroler, Maria Theresia
    Dejaco, Daniel
    Amann, Arno
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (04) : 395 - 399
  • [47] Established treatment concepts for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSSC)
    Marcel Kloppenburg
    Finn Mildner
    Maria Theresia Kasseroler
    Daniel Dejaco
    Arno Amann
    memo - Magazine of European Medical Oncology, 2020, 13 : 395 - 399
  • [48] Clinical biomarkers as predictors of immunotherapy (IT) benefit in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pt)
    Hernando-Calvo, A.
    Mirallas, O.
    Marmolejo, D.
    Felip, E.
    Villacampa Javierre, G.
    Garralda, E.
    Gutierrez, R.
    Feliu, B.
    Martinez, S.
    Dienstmann, R.
    Brana, I.
    ANNALS OF ONCOLOGY, 2019, 30 : 25 - 25
  • [49] Prognostic value of metabolic tumor volume in recurrent and/or metastatic head and neck squamous cell carcinoma treated with platinum-based chemotherapy
    Suzuki, M.
    Takemoto, N.
    Fukuzumi, T.
    Yamamoto, M.
    Otozai, S.
    Yoshii, T.
    Fujii, T.
    Inohara, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [50] Atypical new metastatic sites after immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M H&NSCC)
    Deeken, John F.
    Ahmadi, Mahsa
    Johnston, Laura
    Heyer, David M.
    Lee, Patty
    Niknia, Katherine
    Bajaj, Gopal Krishna
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345